Skip to main content

Research Repository

Advanced Search

Co-expression of nuclear P38 and hormone receptors is prognostic of good long-term clinical outcome in primary breast cancer and is linked to upregulation of DNA repair

Johnston, Simon J.; Ahmad, Dena; Aleskandarany, Mohammed A.; Kurozumi, Sasagu; Nolan, Chris C.; Diez-Rodriguez, Maria; Green, Andrew R.; Rakha, Emad A.

Authors

Simon J. Johnston

Dena Ahmad

Mohammed A. Aleskandarany

Sasagu Kurozumi

Chris C. Nolan

Maria Diez-Rodriguez

EMAD RAKHA Emad.Rakha@nottingham.ac.uk
Professor of Breast Cancer Pathology



Citation

Johnston, S. J., Ahmad, D., Aleskandarany, M. A., Kurozumi, S., Nolan, C. C., Diez-Rodriguez, M., …Rakha, E. A. (2018). Co-expression of nuclear P38 and hormone receptors is prognostic of good long-term clinical outcome in primary breast cancer and is linked to upregulation of DNA repair. BMC Cancer, 18, Article 1027. https://doi.org/10.1186/s12885-018-4924-2

Journal Article Type Article
Acceptance Date Oct 9, 2018
Online Publication Date Oct 23, 2018
Publication Date Oct 23, 2018
Deposit Date Oct 19, 2018
Publicly Available Date Oct 19, 2018
Journal BMC Cancer
Electronic ISSN 1471-2407
Publisher BMC
Peer Reviewed Peer Reviewed
Volume 18
Article Number 1027
DOI https://doi.org/10.1186/s12885-018-4924-2
Keywords Breast cancer; P38; MAPK; Oestrogen receptor; Adjuvant; Survival; Prognosis
Public URL https://nottingham-repository.worktribe.com/output/1176745
Publisher URL https://bmccancer.biomedcentral.com/articles/10.1186/s12885-018-4924-2

Files







You might also like



Downloadable Citations